Provided by Tiger Trade Technology Pte. Ltd.

Instinct Bio Technical Co

0.3533
-0.0198-5.31%
Post-market: 0.35330.00000.00%19:30 EDT
Volume:604.87K
Turnover:210.22K
Market Cap:10.16M
PE:-1.95
High:0.3768
Open:0.3718
Low:0.3398
Close:0.3731
52wk High:50.00
52wk Low:0.3301
Shares:28.75M
Float Shares:8.31M
Volume Ratio:1.01
T/O Rate:7.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1813
EPS(LYR):-0.2549
ROE:--
ROA:--
PB:--
PE(LYR):-1.39

Loading ...

Instinct Bio Named CelSiege Representative for IN01 Cancer Immunotherapy in Japan, China

Reuters
·
Yesterday

Alert Incorrectly Tagged to Instinct Bio Technical Company Withdrawn

Reuters
·
Sep 28

Instinct Raises $1 Billion in Series C Funding from Sequoia, Benchmark and Coatue at $10 Billion Valuation

THOMSON REUTERS
·
Sep 28

Burnham must kill off bonkers Chagos deal for good

cityam
·
Sep 28

Instinct Bio Targets December Opening for First Genrêver Clinic Site in South Jakarta

Reuters
·
Sep 08

Instinct Bio Teams up with Invitrx to Develop Genrêver Cosmetic Product Line in US

Reuters
·
Sep 04

Instinct Bio Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

THOMSON REUTERS
·
Sep 04

Press Release: Instinct BIO Provides Operational Update on Indonesia Growth Platform and Product Development Initiatives

Dow Jones
·
Sep 04

Instinct Bio Partners with Indonesia’s Parva Candela to Expand Cosmetics Business

Reuters
·
Aug 10

Instinct Bio Announces Strategic Collaboration with PT Parva Candela to Develop Cosmetics Business in Indonesia

THOMSON REUTERS
·
Aug 10

BIOT to Launch Indonesia’s First Subscription-Model Beauty Clinics Under Its Own Japanese Brand “GENRÊVER CLINIC” — Building a Recurring-Revenue Platform in One of Asia’s Fastest-Growing Aesthetics Markets

GlobeNewswire
·
Jul 29

Instinct Bio Stock Slides After Hours: Here's What is Going on With BIOT

Benzinga
·
Jul 29

Instinct Bio: Secures $150 Mln Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

THOMSON REUTERS
·
Jul 28

Press Release: Instinct Bio (Nasdaq: BIOT) Secures $150 Million Equity Funding to Advance Regenerative Medicine Platform and Strategic Growth

Dow Jones
·
Jul 28

NASDAQ Trade Halt Volatility Trading Pause at 09:40 Am

Reuters
·
Jul 27

NASDAQ Trade Halt Volatility Trading Pause at 01:50 Pm

Reuters
·
Jul 25

Press Release: Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its NASDAQ Debut Under the Ticker "biot" on July 24, 2026

Dow Jones
·
Jul 24

Instinct Bio Completes Business Combination with Relativity Acquisition Corp. and Makes Its NASDAQ Debut Under the Ticker “biot” on July 24, 2026

THOMSON REUTERS
·
Jul 24